UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction

Journal of the American College of Cardiology, 2016-05, Vol.67 (17), p.2050-2060

2016

Volltextzugriff (PDF)

Intravenously Delivered Mesenchymal Stem Cells

Circulation research, 2017-05, Vol.120 (10), p.1598-1613

2017

Volltextzugriff (PDF)

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

The Journal of experimental medicine, 2008-04, Vol.205 (4), p.799-810

2008

Volltextzugriff (PDF)

Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response

The Journal of immunology (1950), 2009-04, Vol.182 (8), p.4624-4632

2009

Volltextzugriff (PDF)

Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects

PloS one, 2013-10, Vol.8 (10), p.e76115

2013

Volltextzugriff (PDF)

Persistent Inflammation, Stem Cell–Induced Systemic Anti‐Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure

Journal of the American Heart Association, 2018-02, Vol.7 (4), p.n/a

2018

Volltextzugriff (PDF)

Mouse Models of Experimental Autoimmune Uveitis

Ophthalmic research, 2008-01, Vol.40 (3-4), p.169-174

2008

Volltextzugriff (PDF)

Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy

Journal of the American College of Cardiology, 2015-11, Vol.66 (18), p.2038-2047

2015

Volltextzugriff (PDF)

Paracrine-Mediated Systemic Anti-Inflammatory Activity of Intravenously Administered Mesenchymal Stem Cells: A Transformative Strategy for Cardiac Stem Cell Therapeutics

Circulation research, 2017-10, Vol.121 (9), p.1044-1046

2017

Volltextzugriff (PDF)

Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy

Circulation research, 2017-05, Vol.120 (10), p.1598-1613

2017

Volltextzugriff (PDF)

Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion

The Journal of immunology (1950), 2008-04, Vol.180 (8), p.5167-5171

2008

Volltextzugriff (PDF)

Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells

Journal of leukocyte biology, 2008-08, Vol.84 (2), p.577-585

2008

Volltextzugriff (PDF)

Large Animal Model Efficacy Testing Is Needed Prior to Launch of a Stem Cell Clinical Trial: An Evidence-Lacking Conclusion Based on Conjecture

Circulation research, 2017-08, Vol.121 (5), p.496-498

2017

Volltextzugriff (PDF)

Paracrine-Mediated Systemic Anti-Inflammatory Activity of Intravenously Administered Mesenchymal Stem Cells

Circulation research, 2017-10, Vol.121 (9), p.1044-1046

2017

Volltextzugriff (PDF)

Large Animal Model Efficacy Testing Is Needed Prior to Launch of a Stem Cell Clinical Trial

Circulation research, 2017-08, Vol.121 (5), p.496-498

2017

Volltextzugriff (PDF)

New perspectives on effector mechanisms in uveitis

Seminars in immunopathology, 2008-04, Vol.30 (2), p.135-143

2008

Volltextzugriff (PDF)

Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells

Journal of the American College of Cardiology, 2015-11, Vol.66 (18), p.2038-2047

2015

Volltextzugriff (PDF)

Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications

Handbook of experimental pharmacology, 2017-01, Vol.243, p.329-353

2017

Volltextzugriff (PDF)

Neuroprotective effects of IL-22 during CNS inflammation (CCR4P.203)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.118-118.3

2015

Volltextzugriff (PDF)

GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells

Oncogene, 2012-04, Vol.31 (16), p.2017-2027

2012

Volltextzugriff (PDF)

IL-23 and IL-17 in Pathogenesis of Experimental Ocular Autoimmunity: Requirement for IL-23 May Extend Beyond Its Role in Sustaining the IL-17 Effector Response

Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S61-S61

2007

Volltextzugriff (PDF)

Endogenous IL-6 is Required for Inducing and Sustaining an Antigen-specific IL-17 Memory Response in Experimental Autoimmune Uveitis (EAU), but Not for Innate IL-17 Production

Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S62-S62

2007

Volltextzugriff (PDF)

The Role of Apoptosis in the Ameliorating Effects of a CDR1-Based Peptide on Lupus Manifestations in a Mouse Model

Journal of Immunology, 2007-10, Vol.179 (8), p.4979-4987

2007

Volltextzugriff (PDF)

Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101

International journal of molecular medicine, 2011-11, Vol.28 (5), p.727-731

2011

Volltextzugriff (PDF)

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer

Breast cancer research : BCR, 2012-07, Vol.14 (4), p.R109-R109, Article R109

2012

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Animals
(19)
Humans
(15)
Mice
(15)
Inflammation
(9)
Cardiac & Cardiovascular Systems
(8)
Cardiovascular System & Cardiology
(8)
Uveitis - Immunology
(8)
Cardiovascular
(7)
Immunology
(7)
Disease Models, Animal
(6)
Female
(6)
Mice, Inbred C57bl
(6)
Stem Cells
(6)
Cells, Cultured
(5)
Heart Failure
(5)
Hematology
(4)
Male
(4)
Mesenchymal Stem Cell Transplantation - Methods
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction

Intravenously Delivered Mesenchymal Stem Cells

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response

Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects

Persistent Inflammation, Stem Cell–Induced Systemic Anti‐Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure

Mouse Models of Experimental Autoimmune Uveitis

Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy

Paracrine-Mediated Systemic Anti-Inflammatory Activity of Intravenously Administered Mesenchymal Stem Cells: A Transformative Strategy for Cardiac Stem Cell Therapeutics

Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy

Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion

Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells

Large Animal Model Efficacy Testing Is Needed Prior to Launch of a Stem Cell Clinical Trial: An Evidence-Lacking Conclusion Based on Conjecture

Paracrine-Mediated Systemic Anti-Inflammatory Activity of Intravenously Administered Mesenchymal Stem Cells

Large Animal Model Efficacy Testing Is Needed Prior to Launch of a Stem Cell Clinical Trial

New perspectives on effector mechanisms in uveitis

Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells

Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications

Neuroprotective effects of IL-22 during CNS inflammation (CCR4P.203)

GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells

IL-23 and IL-17 in Pathogenesis of Experimental Ocular Autoimmunity: Requirement for IL-23 May Extend Beyond Its Role in Sustaining the IL-17 Effector Response

Endogenous IL-6 is Required for Inducing and Sustaining an Antigen-specific IL-17 Memory Response in Experimental Autoimmune Uveitis (EAU), but Not for Innate IL-17 Production

The Role of Apoptosis in the Ameliorating Effects of a CDR1-Based Peptide on Lupus Manifestations in a Mouse Model

Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer

Suchergebnisse filtern